DLA Piper and Accura has assisted Impilo AB and SHS Capital in the acquisition of the Danish company Lowenco A/S

Founded in 2013 and headquartered in Vamdrup, Denmark, Lowenco is a leading manufacturer of ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance market. The company’s unique, highly energy-efficient, and sustainable ULT storage solutions are developed under LSSU and CON20.

Lowenco is a preferred supplier of sustainable large-scale modular ULT storage solutions to several of the world's largest biotech and pharmaceuticals companies. The management team in Lowenco will remain following the transaction and will be led by CEO Mikael Hoier, who has been part of the management team since 2017.

Impilo and SHS was advised by a DLA Piper team consisting of Karsten Pedersen, Sara Schjørring, and Ida Boysen.

Read the press release from Impilo. 

Read the press release from SHS.